

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sperm capacitation (GO:0048240) | 9.36738688 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 9.02768124 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 9.02768124 |
| 4 | tryptophan catabolic process (GO:0006569) | 9.02768124 |
| 5 | regulation of tolerance induction (GO:0002643) | 8.74463934 |
| 6 | tryptophan metabolic process (GO:0006568) | 7.89517711 |
| 7 | regulation of chronic inflammatory response (GO:0002676) | 7.42665405 |
| 8 | single fertilization (GO:0007338) | 7.14468122 |
| 9 | heterotypic cell-cell adhesion (GO:0034113) | 6.93967625 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 6.88651094 |
| 11 | positive regulation of type 2 immune response (GO:0002830) | 6.09307840 |
| 12 | negative regulation of interleukin-10 production (GO:0032693) | 5.97323814 |
| 13 | amine catabolic process (GO:0009310) | 5.92469214 |
| 14 | cellular biogenic amine catabolic process (GO:0042402) | 5.92469214 |
| 15 | indolalkylamine metabolic process (GO:0006586) | 5.82325724 |
| 16 | benzene-containing compound metabolic process (GO:0042537) | 5.21190293 |
| 17 | aromatic amino acid family metabolic process (GO:0009072) | 5.00215798 |
| 18 | fertilization (GO:0009566) | 4.68256025 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.49490937 |
| 20 | reverse cholesterol transport (GO:0043691) | 4.27031553 |
| 21 | negative regulation of interleukin-8 production (GO:0032717) | 4.19793292 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18405376 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16926650 |
| 24 | indole-containing compound metabolic process (GO:0042430) | 4.08103878 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.95754590 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.95754590 |
| 27 | digestion (GO:0007586) | 3.91980783 |
| 28 | complement activation, alternative pathway (GO:0006957) | 3.88480404 |
| 29 | negative regulation of endopeptidase activity (GO:0010951) | 3.85964021 |
| 30 | cysteine metabolic process (GO:0006534) | 3.84155194 |
| 31 | negative regulation of T cell apoptotic process (GO:0070233) | 3.72705600 |
| 32 | negative regulation of peptidase activity (GO:0010466) | 3.68457562 |
| 33 | phospholipid homeostasis (GO:0055091) | 3.66911559 |
| 34 | positive regulation of cell-cell adhesion (GO:0022409) | 3.65118819 |
| 35 | L-phenylalanine metabolic process (GO:0006558) | 3.64910243 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.64910243 |
| 37 | transepithelial transport (GO:0070633) | 3.59940372 |
| 38 | epithelial cell morphogenesis (GO:0003382) | 3.59725912 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.59404331 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 3.33415291 |
| 41 | cellular amino acid catabolic process (GO:0009063) | 3.17094726 |
| 42 | regulation of type 2 immune response (GO:0002828) | 3.13903066 |
| 43 | N-acetylneuraminate metabolic process (GO:0006054) | 3.02751904 |
| 44 | negative regulation of protein autophosphorylation (GO:0031953) | 3.02239310 |
| 45 | seminiferous tubule development (GO:0072520) | 20.7778898 |
| 46 | valine metabolic process (GO:0006573) | 2.98977856 |
| 47 | regulation of lipoprotein metabolic process (GO:0050746) | 2.98749134 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 2.97107992 |
| 49 | macromolecular complex remodeling (GO:0034367) | 2.97107992 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 2.97107992 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95829412 |
| 52 | defense response to bacterium (GO:0042742) | 2.95803927 |
| 53 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.95563899 |
| 54 | regulation of protein activation cascade (GO:2000257) | 2.91292782 |
| 55 | glutamate metabolic process (GO:0006536) | 2.90405540 |
| 56 | ethanol oxidation (GO:0006069) | 2.87236416 |
| 57 | regulation of complement activation (GO:0030449) | 2.85237652 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 2.84292091 |
| 59 | bile acid biosynthetic process (GO:0006699) | 2.76325102 |
| 60 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.72157915 |
| 61 | hormone catabolic process (GO:0042447) | 2.70244811 |
| 62 | negative regulation of fibrinolysis (GO:0051918) | 2.63862866 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.63730066 |
| 64 | regulation of macrophage activation (GO:0043030) | 2.63604309 |
| 65 | glyoxylate metabolic process (GO:0046487) | 2.62492839 |
| 66 | carboxylic acid catabolic process (GO:0046395) | 2.61615975 |
| 67 | organic acid catabolic process (GO:0016054) | 2.61615975 |
| 68 | regulation of triglyceride catabolic process (GO:0010896) | 2.59401292 |
| 69 | response to bacterium (GO:0009617) | 2.56567455 |
| 70 | low-density lipoprotein particle clearance (GO:0034383) | 2.55747474 |
| 71 | lysine metabolic process (GO:0006553) | 2.54680315 |
| 72 | lysine catabolic process (GO:0006554) | 2.54680315 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 2.54396512 |
| 74 | serine family amino acid catabolic process (GO:0009071) | 2.53621079 |
| 75 | complement activation, classical pathway (GO:0006958) | 2.52559059 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.50526510 |
| 77 | aspartate family amino acid catabolic process (GO:0009068) | 2.49951730 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 2.49496780 |
| 79 | negative regulation of proteolysis (GO:0045861) | 2.46487864 |
| 80 | complement activation (GO:0006956) | 2.46094545 |
| 81 | triglyceride catabolic process (GO:0019433) | 2.44872816 |
| 82 | acylglycerol catabolic process (GO:0046464) | 2.43188681 |
| 83 | neutral lipid catabolic process (GO:0046461) | 2.43188681 |
| 84 | cytolysis (GO:0019835) | 2.40779488 |
| 85 | regulation of fibrinolysis (GO:0051917) | 2.39325836 |
| 86 | negative regulation of protein processing (GO:0010955) | 2.38970656 |
| 87 | negative regulation of protein maturation (GO:1903318) | 2.38970656 |
| 88 | protein carboxylation (GO:0018214) | 2.38916482 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38916482 |
| 90 | urea metabolic process (GO:0019627) | 2.38614622 |
| 91 | urea cycle (GO:0000050) | 2.38614622 |
| 92 | sialylation (GO:0097503) | 2.37906918 |
| 93 | fatty acid oxidation (GO:0019395) | 2.37761518 |
| 94 | negative regulation of lipase activity (GO:0060192) | 2.37609543 |
| 95 | fatty acid catabolic process (GO:0009062) | 2.37576700 |
| 96 | lipid catabolic process (GO:0016042) | 2.37504012 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 11.9926842 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 11.7864837 |
| 99 | kynurenine metabolic process (GO:0070189) | 10.6025339 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 10.0758492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.03846819 |
| 2 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.09191641 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01349762 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.80034035 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40741177 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.36751454 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.30249465 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.21701805 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.98277647 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.91746952 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40705388 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.35497181 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33287665 |
| 14 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.07886057 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.02716355 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01716383 |
| 17 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.97169999 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96474839 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.89801489 |
| 20 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.86441876 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.80883779 |
| 22 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.64168732 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61884286 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60861224 |
| 25 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.58129666 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58060063 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54997842 |
| 28 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.50874643 |
| 29 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.48184757 |
| 30 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47455484 |
| 31 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.46079237 |
| 32 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.44528761 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43436724 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42307148 |
| 35 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.37551420 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37258052 |
| 37 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.34777955 |
| 38 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.34415591 |
| 39 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.33532330 |
| 40 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.30927163 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28185519 |
| 42 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.24278019 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21929853 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21929853 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19454849 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13992584 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13845992 |
| 48 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13694182 |
| 49 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12838787 |
| 50 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12623828 |
| 51 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11322217 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09687620 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09396918 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.09207995 |
| 55 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07830837 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06700162 |
| 57 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04265876 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03680527 |
| 59 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.03459445 |
| 60 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.02513302 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02258986 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01084502 |
| 63 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99936777 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99311792 |
| 65 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95904390 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95511403 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94851148 |
| 68 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.94279335 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94166444 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93686500 |
| 71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92525811 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91944172 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91830217 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90458188 |
| 75 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89930454 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89384925 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88797430 |
| 78 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.86786304 |
| 79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86625962 |
| 80 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85704893 |
| 81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85448210 |
| 82 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.85195539 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84888090 |
| 84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84504343 |
| 85 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84339818 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84123178 |
| 87 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.83732316 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82847905 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82111407 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81542054 |
| 91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81291499 |
| 92 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81241404 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80293980 |
| 94 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.79276809 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78953102 |
| 96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78776133 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78731812 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.78523996 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78315780 |
| 100 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.77781643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.20542335 |
| 2 | MP0003195_calcinosis | 4.90694295 |
| 3 | MP0005360_urolithiasis | 4.29024477 |
| 4 | MP0003303_peritoneal_inflammation | 4.12499684 |
| 5 | MP0002254_reproductive_system_inflammat | 3.96630695 |
| 6 | MP0004043_abnormal_pH_regulation | 3.67317526 |
| 7 | MP0005365_abnormal_bile_salt | 3.63669771 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.62239481 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.92706225 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.86336303 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.58952389 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48399145 |
| 13 | MP0003329_amyloid_beta_deposits | 2.45442120 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.38548665 |
| 15 | MP0005410_abnormal_fertilization | 2.35532159 |
| 16 | MP0003252_abnormal_bile_duct | 2.22851087 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.10553805 |
| 18 | MP0004130_abnormal_muscle_cell | 2.06975960 |
| 19 | MP0005083_abnormal_biliary_tract | 2.06612115 |
| 20 | MP0005332_abnormal_amino_acid | 2.00225407 |
| 21 | MP0000604_amyloidosis | 1.81846015 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.78642272 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.73709252 |
| 24 | MP0009840_abnormal_foam_cell | 1.67458698 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.59660842 |
| 26 | MP0000003_abnormal_adipose_tissue | 1.54196746 |
| 27 | MP0002168_other_aberrant_phenotype | 1.52178254 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51563520 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.41583173 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.41469615 |
| 31 | MP0000747_muscle_weakness | 1.41288002 |
| 32 | MP0000609_abnormal_liver_physiology | 1.38633929 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.30727757 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.28336265 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.28216410 |
| 36 | MP0003690_abnormal_glial_cell | 1.24599693 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.22817018 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.22743842 |
| 39 | MP0004885_abnormal_endolymph | 1.22010758 |
| 40 | MP0001853_heart_inflammation | 1.21800305 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.20812414 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.18298975 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.11135424 |
| 44 | MP0000751_myopathy | 1.09374994 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.08648623 |
| 46 | MP0000749_muscle_degeneration | 1.08599069 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.06633482 |
| 48 | MP0001756_abnormal_urination | 1.04811187 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.04014487 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.01442051 |
| 51 | MP0003566_abnormal_cell_adhesion | 0.98673215 |
| 52 | MP0002971_abnormal_brown_adipose | 0.98055733 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 0.94258858 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 0.93015090 |
| 55 | MP0002796_impaired_skin_barrier | 0.91992531 |
| 56 | MP0005670_abnormal_white_adipose | 0.90352228 |
| 57 | MP0004270_analgesia | 0.88988042 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.86041470 |
| 59 | MP0005334_abnormal_fat_pad | 0.83657752 |
| 60 | MP0004087_abnormal_muscle_fiber | 0.82606947 |
| 61 | MP0000534_abnormal_ureter_morphology | 0.80663252 |
| 62 | MP0003075_altered_response_to | 0.80421801 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 0.80246139 |
| 64 | MP0002269_muscular_atrophy | 0.79947267 |
| 65 | MP0005535_abnormal_body_temperature | 0.79833255 |
| 66 | MP0001764_abnormal_homeostasis | 0.79193011 |
| 67 | MP0005620_abnormal_muscle_contractility | 0.78761179 |
| 68 | MP0002896_abnormal_bone_mineralization | 0.78493570 |
| 69 | MP0004858_abnormal_nervous_system | 0.76085989 |
| 70 | MP0005275_abnormal_skin_tensile | 0.71653597 |
| 71 | MP0004859_abnormal_synaptic_plasticity | 0.70884891 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.70759693 |
| 73 | MP0003632_abnormal_nervous_system | 0.70222600 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.67946273 |
| 75 | MP0000920_abnormal_myelination | 0.66719951 |
| 76 | MP0003868_abnormal_feces_composition | 0.65763566 |
| 77 | MP0005395_other_phenotype | 0.63143822 |
| 78 | MP0000759_abnormal_skeletal_muscle | 0.62670315 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.62002279 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.61943467 |
| 81 | MP0003879_abnormal_hair_cell | 0.59879878 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.59269225 |
| 83 | MP0003959_abnormal_lean_body | 0.58221034 |
| 84 | MP0003631_nervous_system_phenotype | 0.57663898 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.57004839 |
| 86 | MP0009764_decreased_sensitivity_to | 0.56933984 |
| 87 | MP0009763_increased_sensitivity_to | 0.56712667 |
| 88 | MP0005166_decreased_susceptibility_to | 0.56246616 |
| 89 | MP0003633_abnormal_nervous_system | 0.56232783 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.55958821 |
| 91 | MP0000598_abnormal_liver_morphology | 0.55707396 |
| 92 | MP0003698_abnormal_male_reproductive | 0.55518713 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.55469379 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.54083915 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.52356480 |
| 96 | MP0005330_cardiomyopathy | 0.52338364 |
| 97 | MP0000537_abnormal_urethra_morphology | 0.52259271 |
| 98 | MP0000249_abnormal_blood_vessel | 0.51956121 |
| 99 | MP0005408_hypopigmentation | 0.49321444 |
| 100 | MP0003646_muscle_fatigue | 0.47781115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 5.56609293 |
| 2 | Myocardial infarction (HP:0001658) | 4.88946709 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.67639079 |
| 4 | Xanthomatosis (HP:0000991) | 4.48940455 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.43372157 |
| 6 | Hypophosphatemic rickets (HP:0004912) | 4.28536566 |
| 7 | Vascular calcification (HP:0004934) | 4.23178927 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.18427427 |
| 9 | Abnormality of complement system (HP:0005339) | 3.98684132 |
| 10 | Cardiovascular calcification (HP:0011915) | 3.87847235 |
| 11 | Malnutrition (HP:0004395) | 3.71903274 |
| 12 | Potter facies (HP:0002009) | 3.68650284 |
| 13 | Facial shape deformation (HP:0011334) | 3.68650284 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.49056398 |
| 15 | Ketosis (HP:0001946) | 3.47961126 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.43636611 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.38358033 |
| 18 | Hyperglycinuria (HP:0003108) | 3.32817017 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.29811434 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.23575093 |
| 21 | Hyperglycinemia (HP:0002154) | 3.16215224 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.15049257 |
| 23 | Gout (HP:0001997) | 3.14973015 |
| 24 | Ketoacidosis (HP:0001993) | 3.13526626 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.11871642 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.11690054 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.11690054 |
| 28 | Hyperammonemia (HP:0001987) | 3.03482912 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 3.02355874 |
| 30 | Difficulty running (HP:0009046) | 3.01806663 |
| 31 | Epidermoid cyst (HP:0200040) | 3.00664658 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.96659196 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 2.87687900 |
| 34 | Rickets (HP:0002748) | 2.87473512 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.85968663 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 2.82861577 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.82161203 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.75790451 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.72159100 |
| 40 | Calf muscle hypertrophy (HP:0008981) | 2.68284392 |
| 41 | Myoglobinuria (HP:0002913) | 2.66393686 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63441544 |
| 43 | Muscle fiber splitting (HP:0003555) | 2.62173646 |
| 44 | Infantile muscular hypotonia (HP:0008947) | 2.61297704 |
| 45 | Skin nodule (HP:0200036) | 2.54958716 |
| 46 | Choroideremia (HP:0001139) | 2.53750719 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43588086 |
| 48 | Widely patent fontanelles and sutures (HP:0004492) | 2.40613868 |
| 49 | Choreoathetosis (HP:0001266) | 2.40082178 |
| 50 | Intention tremor (HP:0002080) | 2.39535809 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.38529961 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.36904770 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.35643915 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33527164 |
| 55 | Neoplasm of the heart (HP:0100544) | 2.30719882 |
| 56 | Increased connective tissue (HP:0009025) | 2.30586849 |
| 57 | Spastic diplegia (HP:0001264) | 2.23346549 |
| 58 | Agitation (HP:0000713) | 2.20191206 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.16019031 |
| 60 | Cholelithiasis (HP:0001081) | 2.15790248 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.13771041 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12483096 |
| 63 | Supranuclear gaze palsy (HP:0000605) | 2.11609547 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.05378252 |
| 65 | Polar cataract (HP:0010696) | 2.04183951 |
| 66 | Muscle stiffness (HP:0003552) | 2.03960231 |
| 67 | Fat malabsorption (HP:0002630) | 2.03723834 |
| 68 | EMG: myopathic abnormalities (HP:0003458) | 2.02231104 |
| 69 | Acanthosis nigricans (HP:0000956) | 2.01644576 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99880220 |
| 71 | Hypertriglyceridemia (HP:0002155) | 1.97484261 |
| 72 | Testicular atrophy (HP:0000029) | 1.96199244 |
| 73 | Neonatal onset (HP:0003623) | 1.94864103 |
| 74 | Increased purine levels (HP:0004368) | 1.94689787 |
| 75 | Hyperuricemia (HP:0002149) | 1.94689787 |
| 76 | Joint hemorrhage (HP:0005261) | 1.93587877 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93200124 |
| 78 | Oligomenorrhea (HP:0000876) | 1.93117772 |
| 79 | Hemiplegia (HP:0002301) | 1.90659585 |
| 80 | Amyloidosis (HP:0011034) | 1.90486350 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88142166 |
| 82 | Pancreatitis (HP:0001733) | 1.87912887 |
| 83 | Muscle fiber inclusion bodies (HP:0100299) | 1.87733343 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86710926 |
| 85 | Hyperbilirubinemia (HP:0002904) | 1.86675140 |
| 86 | Late onset (HP:0003584) | 1.85638725 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.81739721 |
| 88 | Delayed CNS myelination (HP:0002188) | 1.80110693 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 1.79214180 |
| 90 | Spontaneous abortion (HP:0005268) | 1.79158356 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.78842230 |
| 92 | Cholecystitis (HP:0001082) | 1.78842230 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 1.76345475 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 1.72885310 |
| 95 | Myotonia (HP:0002486) | 1.72590947 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72457963 |
| 97 | Focal segmental glomerulosclerosis (HP:0000097) | 1.71483037 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71445111 |
| 99 | Right ventricular cardiomyopathy (HP:0011663) | 1.71076596 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70032626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.74716920 |
| 2 | SIK1 | 3.19023832 |
| 3 | BCKDK | 2.79326686 |
| 4 | EPHB1 | 2.79236256 |
| 5 | MST4 | 2.79181760 |
| 6 | FGFR4 | 2.54547760 |
| 7 | LMTK2 | 2.49539895 |
| 8 | TTN | 2.45259649 |
| 9 | TRIB3 | 2.35019375 |
| 10 | PKN2 | 2.24331003 |
| 11 | TAOK3 | 2.19012783 |
| 12 | FGFR2 | 2.14118890 |
| 13 | PHKG1 | 2.09356938 |
| 14 | PHKG2 | 2.09356938 |
| 15 | LRRK2 | 1.89320851 |
| 16 | MAP2K4 | 1.89065935 |
| 17 | FER | 1.80954272 |
| 18 | PDGFRA | 1.79215992 |
| 19 | MAP3K7 | 1.58462363 |
| 20 | PTK6 | 1.55371112 |
| 21 | STK39 | 1.52820514 |
| 22 | WNK4 | 1.35020090 |
| 23 | PDK4 | 1.32846839 |
| 24 | PDK3 | 1.32846839 |
| 25 | OBSCN | 1.22300977 |
| 26 | TNK2 | 1.21241170 |
| 27 | MAP3K2 | 1.19902911 |
| 28 | RET | 1.14009737 |
| 29 | PRKD3 | 1.13091841 |
| 30 | PAK3 | 1.09808018 |
| 31 | EPHA2 | 1.07669050 |
| 32 | PIK3CG | 1.06641549 |
| 33 | PTK2B | 1.05281487 |
| 34 | PTK2 | 1.00661616 |
| 35 | NTRK1 | 0.98352879 |
| 36 | KSR2 | 0.97325545 |
| 37 | MYLK | 0.96639413 |
| 38 | TYRO3 | 0.95872825 |
| 39 | DMPK | 0.95008560 |
| 40 | INSRR | 0.93608852 |
| 41 | INSR | 0.91862114 |
| 42 | PAK6 | 0.87575920 |
| 43 | PRKCH | 0.87152686 |
| 44 | FGFR3 | 0.85137972 |
| 45 | MAP3K6 | 0.83661644 |
| 46 | NTRK3 | 0.81327938 |
| 47 | FRK | 0.80874028 |
| 48 | JAK2 | 0.80312009 |
| 49 | MAPK12 | 0.79993466 |
| 50 | GSK3A | 0.78601392 |
| 51 | PRKCG | 0.77598688 |
| 52 | STK10 | 0.76132326 |
| 53 | ERBB4 | 0.75747015 |
| 54 | CDK19 | 0.72591554 |
| 55 | CAMK1G | 0.72266960 |
| 56 | MAP2K1 | 0.71884695 |
| 57 | EPHA4 | 0.71730686 |
| 58 | DAPK2 | 0.70337684 |
| 59 | ICK | 0.70163048 |
| 60 | LATS1 | 0.69166393 |
| 61 | LATS2 | 0.67658467 |
| 62 | PRKACG | 0.66454864 |
| 63 | RIPK4 | 0.66395323 |
| 64 | PDK2 | 0.63932060 |
| 65 | EPHB2 | 0.63585310 |
| 66 | MST1R | 0.62425329 |
| 67 | PAK2 | 0.62099118 |
| 68 | PINK1 | 0.60942873 |
| 69 | PRKCZ | 0.60091386 |
| 70 | FLT3 | 0.59602503 |
| 71 | PRKAA2 | 0.56896574 |
| 72 | CDK5 | 0.56529030 |
| 73 | ERBB2 | 0.56445368 |
| 74 | NTRK2 | 0.55508069 |
| 75 | NEK1 | 0.54049382 |
| 76 | PRKD1 | 0.51366089 |
| 77 | SIK2 | 0.50753448 |
| 78 | FGFR1 | 0.50436571 |
| 79 | SCYL2 | 0.49143562 |
| 80 | MAP2K3 | 0.48769214 |
| 81 | CDK6 | 0.48615746 |
| 82 | MET | 0.47360521 |
| 83 | PDPK1 | 0.46769685 |
| 84 | PRKCQ | 0.46491140 |
| 85 | CAMK2G | 0.46062499 |
| 86 | CSNK1E | 0.45144636 |
| 87 | STK38 | 0.45100991 |
| 88 | MAPK4 | 0.44461690 |
| 89 | JAK1 | 0.44074461 |
| 90 | PDK1 | 0.43960071 |
| 91 | SRC | 0.43476524 |
| 92 | RIPK1 | 0.43026023 |
| 93 | MAP3K12 | 0.42409928 |
| 94 | TESK1 | 0.41725438 |
| 95 | EGFR | 0.41666519 |
| 96 | ABL2 | 0.41521795 |
| 97 | PIK3CA | 0.41309365 |
| 98 | CAMK1D | 0.40499912 |
| 99 | ALK | 0.40399281 |
| 100 | CSK | 0.40005532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.00638913 |
| 2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.53837461 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30043307 |
| 4 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.28736053 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.14867389 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.68180947 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48963014 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45389677 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.44487683 |
| 10 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.28229291 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.27190926 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24764289 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13718419 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05541116 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98022545 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91700359 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81813164 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81737696 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78997871 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72427015 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61360808 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53909042 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53635113 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51640984 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31901587 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31370282 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28591180 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24609677 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.24187719 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21832277 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16882537 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16570455 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.15571824 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14028723 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13960965 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09937163 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04354470 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01472971 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00462662 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98762050 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97086778 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97043055 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94161327 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92080315 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90801821 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90527149 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86832433 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84415934 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82238923 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80911872 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77723890 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74661296 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71879340 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.70307911 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.69642216 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.69598977 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69397963 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67287089 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65707106 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65367656 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61565286 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59283958 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.59158707 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57851716 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54688623 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54609995 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.54376124 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51469567 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49970503 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48671837 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48105258 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46089405 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44739845 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.40332104 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37250747 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31073261 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30073654 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29515009 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27293506 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27212938 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25918576 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23640088 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23499751 |
| 84 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.22963139 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22644093 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22615003 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21035921 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.19985263 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19539200 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17262450 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14842985 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.13068518 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.13034571 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11412020 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11032045 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.10727425 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.09408111 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09091147 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.08379316 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08178737 |

